Wells Fargo & Company Astrazeneca PLC Call Options Transaction History

Wells Fargo & Company

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $3.95 Million - $4.56 Million	83,800 Added 42.01%	283,300 $14.1 Million
Q4 2020 Feb 09, 2021	BUY	$48.52 - $58.02 $7.25 Million - $8.67 Million	149,500 Added 299.0%	199,500 $18,000
Q3 2020 Nov 05, 2020	SELL	$53.07 - $61.1 $2.65 Million - $3.06 Million	-50,000 Reduced 50.0%	50,000 $20,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $4.31 Million - $5.53 Million	100,000 New	100,000 $28,000

1,360

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.